Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy of Polyclonal Antibodies in Simultaneous Pancreas Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 observational study update evaluating the safety and efficacy of polyclonal antibodies in recipients of simultaneous pancreas-kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage
• Diabetes Mellitus
• Simultaneous Pancreas-kidney Transplantation

Drugs mentioned

• Polyclonal antibodies

Snippet

Sponsor: Tianjin First Central Hospital | Conditions: CKD (Chronic Kidney Disease) Stage 5T, Diabetes Mellitus | Phase 4 | Status: UNKNOWN